Eastman Chemical Q2 Earnings Beat Overshadowed by Fibers Weakness and Rising Debt
EMN sits 21% above its 52-week low of $56.11.
Summary
Eastman Chemical beat Q2 2026 consensus with $2.51B revenue and $1.97 adjusted EPS, but Fibers segment profit fell 56% and net debt climbed to $4.53B.
Key Events · Earnings and Guidance · EMN
-
Q2 Revenue and EPS Beat
Revenue of $2.51 billion (up 10% YoY) beat the $2.40 billion consensus. Adjusted EPS of $1.97 exceeded the $1.60 consensus, driven by strong Chemical Intermediates performance.
-
Chemical Intermediates Swing to Profit
The Chemical Intermediates segment posted a $58 million profit vs. a $30 million loss a year ago, fueled by higher selling prices and lower raw material and energy costs.
-
Fibers Segment Profit Plunges
Fibers EBIT fell 56% to $36 million as customers continued destocking acetate tow inventory and textiles demand remained weak.
-
Net Debt Rises to $4.53 Billion
Net debt increased to $4.53 billion from $4.22 billion at year-end 2025, reflecting higher borrowings and lower cash.
Analysis · EMN · Industrial Applications And Services
Eastman Chemical delivered a strong headline beat for Q2 2026, with revenue of $2.51 billion and adjusted EPS of $1.97 topping consensus. The Chemical Intermediates segment swung to a $58 million profit from a $30 million loss a year ago, driven by higher selling prices and lower raw material costs. However, the Fibers segment saw EBIT drop 56% to $36 million as customers continued destocking acetate tow inventory. Net debt rose to $4.53 billion from $4.22 billion at year-end 2025, and the company temporarily relaxed its credit facility leverage covenant through mid-2027, signaling caution about near-term macroeconomic uncertainty. The mixed results—strong in chemicals, weak in fibers—paint a picture of a company navigating uneven end-market demand while managing a heavier debt load.
At the time of this filing, EMN was trading at $67.85 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.8B. The 52-week trading range was $56.11 to $83.47. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.